Yeji
PDUFAconf 0.98

patisiran — PDUFA

$ALNY · ALNYLAM PHARMACEUTICALS, INC. · cardiomyopathy of transthyretin-mediated (ATTR) amyloidosis
Event date
October 8, 2023
972 days ago
Sponsor runway
cash-flow +
$1.66B liquid

Evidence

the FDA has set an action date of October 8, 2023 under the Prescription Drug User Fee Act.
Source: Press release · 2023-06-30View press release ↗

Comparable historical pdufas· last 5 years · same event type

75% hit rate (3/4)
TickerDrugDateOutcome
$RCKTkresladi2026-03-28success
$RYTMimcivree2026-03-20success
$CYTKaficamten2025-12-26unknown
$ALDXreproxalap2025-12-16unknown
$BCRXorladeyo2025-12-12success
$OMERnarsoplimab2025-09-25unknown
$BCRXorladeyo (berotralstat)2025-09-12unknown
$ETONet-4002025-05-28unknown
$ALDXreproxalap2025-04-02failure
$IONSolezarsen2024-12-19unknown

Recent insider activity· ±90 days

5 insiders · 0 buys · 35 sells
Sell10b5-1
2023-12-27
BONNEY MICHAEL W
Director
30,000 @ $195.00$5.85M
Exercise10b5-1
2023-12-27
BONNEY MICHAEL W
Director
30,000 @ $96.45$2.89M
Sell
2023-08-07
Garg Pushkal
EVP Chief R&D
240 @ $185.32$44K
Sell
2023-08-07
Garg Pushkal
EVP Chief R&D
3,112 @ $183.58$571K
Sell
2023-08-07
Garg Pushkal
EVP Chief R&D
814 @ $184.65$150K
Sell
2023-08-04
Garg Pushkal
EVP Chief R&D
15 @ $188.40$3K
Sell
2023-08-04
Garg Pushkal
EVP Chief R&D
164 @ $189.31$31K
Sell
2023-08-04
Poulton Jeffrey V.
EVP, Chief Financial Officer
944 @ $186.39$176K
Sell
2023-08-04
Garg Pushkal
EVP Chief R&D
658 @ $184.70$122K
Sell
2023-08-04
Garg Pushkal
EVP Chief R&D
1,593 @ $185.54$296K
Sell
2023-08-04
Garg Pushkal
EVP Chief R&D
945 @ $186.39$176K
Sell
2023-08-04
Garg Pushkal
EVP Chief R&D
86 @ $187.37$16K
Sell
2023-08-04
Poulton Jeffrey V.
EVP, Chief Financial Officer
1,593 @ $185.54$296K
Sell
2023-08-04
Poulton Jeffrey V.
EVP, Chief Financial Officer
86 @ $187.37$16K
Sell
2023-08-04
Poulton Jeffrey V.
EVP, Chief Financial Officer
15 @ $188.40$3K
Sell
2023-08-04
Poulton Jeffrey V.
EVP, Chief Financial Officer
164 @ $189.31$31K
Sell
2023-08-04
Greenstreet Yvonne
Chief Executive Officer
771 @ $184.70$142K
Sell
2023-08-04
Greenstreet Yvonne
Chief Executive Officer
1,869 @ $185.54$347K
Sell
2023-08-04
Greenstreet Yvonne
Chief Executive Officer
1,107 @ $186.39$206K
Sell
2023-08-04
Greenstreet Yvonne
Chief Executive Officer
101 @ $187.37$19K
Sell
2023-08-04
Greenstreet Yvonne
Chief Executive Officer
17 @ $188.40$3K
Sell
2023-08-04
Greenstreet Yvonne
Chief Executive Officer
192 @ $189.31$36K
Sell
2023-08-04
Vaishnaw Akshay
President
771 @ $184.70$142K
Sell
2023-08-04
Vaishnaw Akshay
President
1,869 @ $185.54$347K
Sell
2023-08-04
Vaishnaw Akshay
President
1,107 @ $186.39$206K
Sell
2023-08-04
Vaishnaw Akshay
President
101 @ $187.37$19K
Sell
2023-08-04
Vaishnaw Akshay
President
17 @ $188.40$3K
Sell
2023-08-04
Vaishnaw Akshay
President
192 @ $189.31$36K
Sell
2023-08-04
Poulton Jeffrey V.
EVP, Chief Financial Officer
658 @ $184.70$122K
Grant
2023-08-03
Garg Pushkal
EVP Chief R&D
3,109 @
Grant
2023-08-03
Poulton Jeffrey V.
EVP, Chief Financial Officer
4,518 @
Grant
2023-08-03
Poulton Jeffrey V.
EVP, Chief Financial Officer
3,109 @
Sell
2023-08-03
BONNEY MICHAEL W
Director
300 @ $181.08$54K
Grant
2023-08-03
Vaishnaw Akshay
President
5,082 @
Grant
2023-08-03
Garg Pushkal
EVP Chief R&D
4,518 @
Grant
2023-08-03
Vaishnaw Akshay
President
3,859 @
Sell
2023-08-03
BONNEY MICHAEL W
Director
500 @ $182.45$91K
Sell
2023-08-03
BONNEY MICHAEL W
Director
560 @ $183.75$103K
Grant
2023-08-03
Greenstreet Yvonne
Chief Executive Officer
5,082 @
Grant
2023-08-03
Greenstreet Yvonne
Chief Executive Officer
3,859 @
Sell
2023-08-03
BONNEY MICHAEL W
Director
1,535 @ $184.89$284K
Sell
2023-08-03
BONNEY MICHAEL W
Director
1,714 @ $185.99$319K
Sell
2023-08-03
BONNEY MICHAEL W
Director
1,389 @ $187.04$260K
Sell
2023-08-03
BONNEY MICHAEL W
Director
450 @ $187.71$84K
Exercise
2023-08-02
BONNEY MICHAEL W
Director
22,477 @